Chong Kun Dang Pharmaceutical (XKRX:185750) Purchase Of Investment : ₩-356,527 Mil (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Purchase Of Investment?

Chong Kun Dang Pharmaceutical's purchase of investment for the three months ended in Mar. 2025 was ₩-56,340 Mil. It means Chong Kun Dang Pharmaceutical spent ₩56,340 Mil on purchasing investments. Chong Kun Dang Pharmaceutical's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-356,527 Mil.

Compared with last quarter (₩-69,986 Mil in Dec. 2024 ), Chong Kun Dang Pharmaceutical spent less money on purchasing investments in Mar. 2025 (₩-56,340 Mil).

Chong Kun Dang Pharmaceutical Purchase Of Investment Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Purchase Of Investment Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Investment

Get a 7-Day Free Trial

-59,956.71

-61,266.43

-57,181.15

-192,468.23

-430,834.49

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Purchase Of Investment	Get a 7-Day Free Trial															-130,648.10	-137,440.24	-92,760.22	-69,985.93	-56,340.22

Chong Kun Dang Pharmaceutical Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-356,527 Mil.

Chong Kun Dang Pharmaceutical Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Purchase Of Investment

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical Headlines

No Headlines